Multiplex fluorescence in situ hybridization testing for anaplastic lymphoma kinase and c-ros oncogene 1 gene rearrangements on cytology smears in lung adenocarcinomas: comparative study with formalin-fixed paraffin-embedded sections-Reference-Cited by-同舟云学术

Multiplex fluorescence in situ hybridization testing for anaplastic lymphoma kinase and c-ros oncogene 1 gene rearrangements on cytology smears in lung adenocarcinomas: comparative study with formalin-fixed paraffin-embedded sections

Published:2022-05 Issue:3 Volume:11 Page:154-164
ISSN:2213-2945
Container-title:Journal of the American Society of Cytopathology
language:en
Short-container-title:Journal of the American Society of Cytopathology

Author:

Nambirajan Aruna,Rana Deeksha,Samant Komal,Prabakaran Aswini,Malik Prabhat,Jain Deepali^ORCID

Funder

ICMR

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference37 articles.

1. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

2. ALK testing with IHC;Thunnissen,2016

3. ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients;Uruga;Pharmgenomics Pers Med,2018

4. ALK immunohistochemistry in NSCLC: discordant staining can impact patient treatment regimen;Ibrahim;J Thorac Oncol,2016

5. KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer;Takeuchi;Clin Cancer Res,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non–Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls;Archives of Pathology & Laboratory Medicine;2023-12-06

2. Molecular Diagnostics of Lung Cancer in Serous Effusion Samples;Journal of Molecular Pathology;2022-04-12